Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

S.J. Lubner, M.R. Mahoney, J.L. Kolesar, N.K. Loconte, G.P. Kim, H.C. Pitot, P.A. Philip, J. Picus, W.P. Yong, Guy Van Hazel, C.E. Erlichman, K.D. Holen

    Research output: Contribution to journalArticlepeer-review

    242 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3491-3497
    JournalJournal of Clinical Oncology
    Volume28
    Issue number21
    DOIs
    Publication statusPublished - 2010

    Cite this